Van Cutsem E - Search Results

1

Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy.

de Haas S, Delmar P, Bansal AT, Moisse M, Miles DW, Leighl N, Escudier B, Van Cutsem E, Carmeliet P, Scherer SJ, Pallaud C, Lambrechts D. de Haas S, et al. Among authors: van cutsem e. Angiogenesis. 2014 Oct;17(4):909-20. doi: 10.1007/s10456-014-9438-1. Epub 2014 Jul 11. Angiogenesis. 2014. PMID: 25012543

2

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials.

Miles D, Harbeck N, Escudier B, Hurwitz H, Saltz L, Van Cutsem E, Cassidy J, Mueller B, Sirzén F. Miles D, et al. Among authors: van cutsem e. J Clin Oncol. 2011 Jan 1;29(1):83-8. doi: 10.1200/JCO.2010.30.2794. Epub 2010 Nov 22. J Clin Oncol. 2011. PMID: 21098326

3

Lessons from the adjuvant bevacizumab trial on colon cancer: what next?

Van Cutsem E, Lambrechts D, Prenen H, Jain RK, Carmeliet P. Van Cutsem E, et al. J Clin Oncol. 2011 Jan 1;29(1):1-4. doi: 10.1200/JCO.2010.32.2701. Epub 2010 Nov 29. J Clin Oncol. 2011. PMID: 21115866 No abstract available.

4

Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.

Zwierzina H, Bardelli A, Ciardiello F, Gariboldi M, Håkansson L, Lambrechts D, Lind GE, Loeffler-Ragg J, Schmoll H, Siena S, Tabernero J, Van Cutsem E. Zwierzina H, et al. Among authors: van cutsem e. Curr Opin Mol Ther. 2010 Dec;12(6):703-11. Curr Opin Mol Ther. 2010. PMID: 21154162 Review.

5

Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.

Cassidy J, Saltz L, Twelves C, Van Cutsem E, Hoff P, Kang Y, Saini JP, Gilberg F, Cunningham D. Cassidy J, et al. Among authors: van cutsem e. Ann Oncol. 2011 Dec;22(12):2604-2609. doi: 10.1093/annonc/mdr031. Epub 2011 Mar 17. Ann Oncol. 2011. PMID: 21415237 Free article.

6

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.

Van Cutsem E, de Haas S, Kang YK, Ohtsu A, Tebbutt NC, Ming Xu J, Peng Yong W, Langer B, Delmar P, Scherer SJ, Shah MA. Van Cutsem E, et al. J Clin Oncol. 2012 Jun 10;30(17):2119-27. doi: 10.1200/JCO.2011.39.9824. Epub 2012 May 7. J Clin Oncol. 2012. PMID: 22565005 Clinical Trial.

7

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials.

Lambrechts D, Claes B, Delmar P, Reumers J, Mazzone M, Yesilyurt BT, Devlieger R, Verslype C, Tejpar S, Wildiers H, de Haas S, Carmeliet P, Scherer SJ, Van Cutsem E. Lambrechts D, et al. Among authors: van cutsem e. Lancet Oncol. 2012 Jul;13(7):724-33. doi: 10.1016/S1470-2045(12)70231-0. Epub 2012 May 17. Lancet Oncol. 2012. PMID: 22608783

8

Genetic markers of bevacizumab-induced hypertension.

Lambrechts D, Moisse M, Delmar P, Miles DW, Leighl N, Escudier B, Van Cutsem E, Bansal AT, Carmeliet P, Scherer SJ, de Haas S, Pallaud C. Lambrechts D, et al. Among authors: van cutsem e. Angiogenesis. 2014 Jul;17(3):685-94. doi: 10.1007/s10456-014-9424-7. Epub 2014 Feb 21. Angiogenesis. 2014. PMID: 24558090

9

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.

Lambrechts D, Thienpont B, Thuillier V, Sagaert X, Moisse M, Peuteman G, Pericay C, Folprecht G, Zalcberg J, Zilocchi C, Margherini E, Chiron M, Van Cutsem E. Lambrechts D, et al. Among authors: van cutsem e. Br J Cancer. 2015 Sep 29;113(7):1027-34. doi: 10.1038/bjc.2015.329. Epub 2015 Sep 10. Br J Cancer. 2015. PMID: 26355232 Free PMC article. Clinical Trial.

10

Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.

Hacker UT, Escalona-Espinosa L, Consalvo N, Goede V, Schiffmann L, Scherer SJ, Hedge P, Van Cutsem E, Coutelle O, Büning H. Hacker UT, et al. Among authors: van cutsem e. Br J Cancer. 2016 Apr 12;114(8):855-62. doi: 10.1038/bjc.2016.30. Epub 2016 Mar 31. Br J Cancer. 2016. PMID: 27031850 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

739 results

Search Page

Filters